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Many human cancers that are widely prevalent today can be
prevented through modifications in life-styles, of which diet
appears to be an important agent. Several dietary constituents
modulate the process of carcinogenesis and prevent geno-
toxicity. Many plant constituents including turmeric appear
to be potent antimutagens and antioxidants. Therefore the
modulatory effects of turmeric and curcumin on the levels
of benzo[a]pyrene induced DNA adducts in the livers of rats
were studied by the newly developed ^P-postlabelllng assay
method. Turmeric when fed at 0.1, 0.5 and 3% and the active
principle of turmeric (curcumin) when fed at a level of 0.03%
in the diet for 4 weeks significantly reduced the level of
BP-DNA adducts including the major adduct dG-N2-BP,
formed within 24 h in response to a single i.p. injection of
benzo[a]pyrene. The significance of these effects in terms of
the potential antkarcinogenk effects of turmeric is discussed.
Further, these results strengthen the various other biological
effects of turmeric which have direct relevance to anti-
carcinogenesis and chemopre vent ion.
Introduction
Several human cancers appear to have a strong environmental
component (1). It is now well accepted that dietary habits play
an important role in a number of major human cancers (2). With
new approaches to detect and treat cancer and better under-
standing of the process of carcinogenesis, cancer prevention and
control appear to be feasible through modification of life-style
factors (3). Besides the role of nutrients as major modulators of
the carcinogenic process, several minor non-nutrient dietary con-
stituents appear to be promising as chemopreventive agents (4,5).
As dietary habits are specific to populations and are varied,
it is necessary to assess the antimutagenic or anticarcinogenic
potentials of substances which are in common use. Since man
gathered and cooked foods, spices have been used to make the
food more appetizing as they add taste and aroma. Turmeric,
a rhizomatous herb, its oleoresin and curcumin, the yellow
pigment in turmeric, are all in use for their colour, flavour and
medicinal properties (6). The major species of genus curcuma
is Curcuma longa Linn, a predominant species yielding turmeric
and curcumin of commercial value.
Using the Ames test, Nagabhushan and Bhide (7) have shown
that turmeric is non-mutagenic and by itself can antagonize the
mutagenicity of other substances. Further, Nagabhushan et al.
(8) tested the effects of curcumin on mutagenicity induced by
environmental agents and concluded that curcumin may alter the
•Abbreviations: BP, benzo[a]pyrene; DMSO, dimethylsulphoxide; RAL,
relative adduct labelling.
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metabolic activation and detoxification of mutagens. Our recent
studies on in vivo mutagenicity in experimental animals and also
human smokers (9,10) have revealed the strong antimutagenic
potentials of turmeric. Apart from mutagenesis, carcinogen
covalent binding to DNA is considered to be a key event in the
initiation process (11). The objective of this paper is to examine
the effects of turmeric/curcumin on DNA adducts analysed and
quantified by the 32P-postlabelling assay in experimental rats.
Materials and methods
All the materials used in this study were similar to those prescribed by Gupta
a al. (12). The fine chemicals were obtained from Sigma Chemical Co., St Louis,
MO. All other chemicals used were of highest purity available. Carrier-free
[32P]orthophosphate (100-150 mCi/ml) used for the synthesis of ATP was
obtained from the Bhabha Atomic Centre, Bombay, India. MN-300 cellulose was
obtained from Brinkman and Co., USA. Turmeric used in this study was obtained
as rhizomes from a local market and was powdered and incorporated into a 20%
casein diet. Curcumin was a generous gift form the Central Drug Research
Institute, Lucknow, India.
Male rats of the Wistar/NFN strain weighing — 100 g were divided into seven
groups of six animals each. The animals were fed on a stock diet containing 20%
casein, 64% starch, 5% fat and vitamins and minerals mix with or without turmeric
or curcumin. Groups I—in received neither turmeric nor curcumin while rats
in groups FV, V and VI received turmeric at 0.1, 0.5 and 3 % levels in the diet,
respectively, and group VII received curcumin at 0.03% in the diet. The animals
were housed in individual cages at 22 ±2°C and allowed free access to their
respective diets and water. They were maintained on a diurnal cycle of 12 h
light/dark. At the end of 1 month, the rats in groups ITJ-Vrj received a single
i.p. injection of benzo{a]pyrene (BP*) (1 mg/kg body wt) in dimethylsulphoxide
(DMSO). Rats in group I received no treatment while those in group II received
DMSO (vehicle) alone. After 24 h of carcinogen/vehicle treatment the animals
were killed by cervical dislocation and the livers were collected, washed in cold
saline, blotted under folds of filter paper, packed in aluminium foil and stored
at -60"C until use for isolation of DNA and analysis of adducts.
Isolation of DNA
DNA was isolated from the liver by solvent extraction after enzymatic digestion
of protein and RNA (13). DNA concentrations were estimated spectrophoto-
metrically using a value of 20 A ^ ""its of DNA per mg.
Digestion of DNA
A known aliquot of DNA was hydrolysed using mkrococcal nuclease and spleen
phosphodiesterase to deoxyribonucleoside 3'-monophosphates (12). An aliquot
of this total DNA digest was diluted and used for the estimation of total nucleotides
by one-dimensional TLC in the ^P-postlabelling procedure. The remaining digest
was used for the estimation of adducted nucleotides by the adduct enrichment
procedure of Gupta (14). It involves extraction of the adducts with 1-butanol in
the presence of the phase transfer agent tetra butyl ammonium ions.
Preparation of TLC sheets
Locally available X-ray sheets were coated with MN-300 cellulose. Prior to
washing the sheets were subjected with dilute acid, alkali and petroleum ether.
Final washing was done with distilled water. After drying, the sheets were coated
with 5% polyethyleneimine-MN 300 cellulose slurry. After overnight drying the
sheets were left in deionized water to remove impurities, followed by air drying
at room temperature. The sheets were cut into appropriate sizes and used
for the study. The sheets thus prepared were found to be as good as commercially
available precoated sheets.
Synthesis of r-nP-labelled ATP
ATP was synthesized by the substrate level phosphorylation of ADP using
carrier-free 32P-orthophosphoric acid by the procedure of Jhonson and Walseth
(15). The ATP synthesized under these conditions was tested by running a
one-dimensional TLC with 1.2 M LiCI and identified by autoradiography. The
specific activity of ATP used in the present study was — 3000 Ci/mmol based
on polynucleotide kinsae catalyzed phosphorylation of a known amount of DNA
493
 by guest on February 7, 2011
ca
rcin.oxfordjournals.org
D
ow
nloaded from
 
M.A.Mukundan el al.
r
n
Fig. 1. DNA fingerprints of rats treated with A, BP at 1 mg/kg body wt; B, BP + 0 . 1 % turmeric in the diet; C, BP + 0.5% turmeric in the diet;
D, BP + 0 .03% curcumin in the diet.
nucleotides. For labelling purposes - 1 0 0 - 1 2 0 /iCi of [y-^PJATP was used for
10 /tg DNA digest.
Labelling and quantification
32P-Labelling of total nucleotides and the isolated adducts, the purification
and resolution of 32P-labelled adducts by multidimensional chromatography,
autoradiographic detection, Cerenkov counting and calculation of relative adduct
labelling (RAL) were done as described by Gupta (14).
Results
The ATP32 synthesized to label the nucleotides when subjected
to ascending PEI-cellulose TLC with 1.2 M LiCl had only one
spot corresponding to ATP appearing near the origin indicating
its purity. That ATP32 did not stay at the origin with the adducts
was verified by running the labelled ATP in one-dimensional TLC
with 1 M sodium phosphate buffer (D, system for adduct
purification). More than 99% of the ATP moved along with
the solvent front.
Total nucleotides (normals) were eluted by low-salt elution
(0.2 M LiCl) in one-dimensional TLC, under which 32Pi
migrated, leaving nucleotides at the origin. High salt (0.8 M
ammonium formate) resolution of the digest showed no
contamination at the origin and the bases were separated along
with Pi, indicating complete DNA digestion and quantitative
labelling of the resultant nucleotides.
Effect of turmeric and curcumin on BP adducts
When the DNA from rat liver treated with BP was analysed for
BP—DNA adducts by the 32P-postlabelling assay, several
radioactive spots were noted (Figure 1 A). In addition to the major
adduct located diagonally to the origin, the sample exhibited a
grey area extending from the origin to the upper left hand margin
and the top extreme right end of the autoradiograms. No attempts
were made in the present study to identify the major adduct
by any standard procedures. The total RAL estimates were
41.08 fmol//ig DNA or 1.37 adducts per 105 nucleotides (Table
I). With 0.1% turmeric alone, the major adduct and the other
radioactive spots disappeared leaving a fairly high intense spot
at the origin (Figure IB), and a less intense spot with 0.5%
turmeric (Figure 1C). Further increase in turmeric level in the
diet (3%) did not seem to have an additive effect (Table I).
However, curcumin, the active principle of turmeric at a level
of 0.03% in the diet, reduced remarkably the intensity of the
spot at the origin as well as the other spots (Figure ID). The
total RAL was just 3.47 fmol//ig DNA and is significantly lower
than that of 0.1, 0.5 and 3% turmeric. Figure 2 shows the
effect of different levels of turmeric and curcumin on BP—DNA
adduct level as per cent of control values. Autoradiographs
from untreated and vehicle treated rats showed a negligible
number of spots.
Table
No.
1
2
3
4
5
I. 1Effect of turmeric and
Treatment
Control BP treated
BP
BP
BP
BP
+ 0.1% turmeric
+ 0.5% turmeric
+ 3% turmeric
+ 0.03% curcumin
curcumii
RAL •
l on BP-DNA adducts
values
(fmol/Mg
41.08
15.91
9.72
12.11
3.47
±
±
±
±
±
DNA)
9.226*
2.077**"
4.848**"
8.173**bc
2.453**1
Mean no. of adducts
per 105
1.37 ±
0.53 ±
0.32 ±
0.39 ±
0.11 ±
nucleotides
0.307
0.067
0.167
0.272
0.082
Values bearing different superscripts are significantly different
(Mann—Whitney U-Wilcoxon rank test).
**P < 0.01, significantly different from control values.
ih
jh
0.1* o n i «
Fig. 2. BP —DNA adduct levels as a percentage of control values in
turmeric and curcumin treated rats (means ± SE).
Discussion
Carcinogenesis induced by chemicals, viruses, radiation, etc.,
involves separate and independent processes of initiation,
promotion and progression (16,17). In theory, there are several
possible ways in which diet can influence human carcinogenesis.
Dietary substances that interfere with formation of carcinogens
from precursors and those that decrease the binding of electro-
philic substances with critical nucleophilic macromolecules, most
importantly DNA, can be considered to be excellent blocking
or inhibitory agents.
Epidemiological and experimental studies suggest an important
role for dietary constituents in carcinogenesis. Chemoprevention
with nutrients and non-nutrients as a prescriptive approach in
addition to proscription is an attractive alternative in cancer
control. Therefore, in the present study an attempt has been made
to identify a naturally occurring anticarcinogen, among the dietary
substances which is routinely used in the Indian cuisine.
One of the primary events in chemical carcinogenesis is the
formation of covalent carcinogen—DNA adducts and as a
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consequence of covalent interaction in vivo, point mutations may
arise and initiate carcinogenesis in susceptible target tissues (18).
Therefore using the 32P-postlabelling assay which measures one
adduct per 107~9 nucleotides, the effects of turmeric and
curcumin on BP-DNA adducts have been quantified. Adduct
enrichment with butanol extraction appears to be generally
greater than with other enzymatic enrichment procedures. Rat
livers treated with BP when analysed for BP-DNA adducts by
the 32P-postlabelling assay resulted in several radioactive spots
(19). In addition to the major spot diagonal to the origin, several
other spots were observed (20). It is obvious from the results
that even as small a dose as 0.1% turmeric in the diet can
significantly remove BP-DNA adducts in hepatic tissues. Dose
responses, however, were not seen. At even 0.1 %, the inhibition
was >60%. Species and strain variation, the dose and the
route employed and the time of killing do not permit us to
compare our results with those documented in literature (21).
Turmeric and curcumin totally inhibited the formation of the
spot diagonal to the origin. Based on its migration on the TLC
sheet it seems to be the major adduct dG-N2-BP as reported
previously (22) which is known to be responsible for mutagenesis
and carcinogenesis (23).
It is even more interesting and encouraging to observe that as
low as a concentration of 0.03% curcumin is more effective
(>90% inhibition) than 0.1% turmeric. Curcumin by structure
is a diferuloyl methane and is a phenolic derivative. Curcumin
has been shown to be a strong antioxidant in vitro (24). Turmerin,
a peptide recently isolated and characterized, also appears to be
an efficient antioxidant (25). Our observations on curcumin,
however, suggest that in addition to being a potent antioxidant,
it can account for 90% inhibition of covalent binding. Further,
our study on curcumin administered by oral route clearly shows
that it is absorbed and is available for biological action whereas
the in vitro efficacy of the peptide needs further evaluation under
in vivo situations.
More recently, we have assessed the effects of turmeric on
xenobiotic metabolizing enzymes which further attributes
detoxifying properties to turmeric (26). Thus, turmeric, its active
ingredient curcumin and probably its peptide component are all
excellent inhibitors of the process of carcinogenesis. They may
act as detoxificants, antioxidants and as anti-initiators. Bhide and
co-workers (27) have documented inhibition of DNA single strand
breaks in the forestomach tumours induced by BP. Our recent
observations have demonstrated a protective effect of curcumin
on DNA single strand breaks induced by genotoxicants in
Saccharomyces cerevisiae suggesting enhancement of DNA repair
process (in press). All these observations reinforce the
anti-initiating effect of turmeric and are in keeping with inhibition
of BP induced forestomach tumours and spontaneous mammary
tumours in mice (28), skin tumours in mice (29) and anti-
tumouricidal effects in culture cells (30).
From the experimental data presented in this and our previous
studies, it is evident that turmeric at levels of 0.1 -0 .5 % in the
diet can decrease DNA adducts and mutagen load. An adult man
weighing ~ 50 kg requires - 500 mg of turmeric per day as
0.1% is found to be active. Although the FAO/WHO expert
committee on food additives estimated the acceptable daily
intake of turmeric and curcumin up to 2.5 mg and 0.1 mg/kg
body wt respectively (31,32), several recent studies demonstrated
that turmeric or curcumin have no adverse effects even when
used at high doses for long periods in experimental animals
as well as in humans, under both in vitro and in vivo
conditions (6,33 — 35).
Dietary interventions appear to be more attractive alternatives
to chemoprevention as they can become part of our daily life-style
changes. Spices in India are part of our regular diet and population
surveys indicate that consumption of turmeric ranges between
0.2 and 0.6 gm/cu/day (36). Turmeric, by virtue of several
mechanisms of anticarcinogenic activity, appears to be a
promising dietary agent for use in humans. Randomized trials
using short term definitive end points in subjects with pre-
cancerous lesions would perhaps establish the efficacy of this
interesting dietary spice used in most South and South East Asian
countries. Further studies are required to establish more clearly
its efficacy in the human situation. Plants and plant products are
perhaps the answer for prevention of several cancers.
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